Association between the serum uric acid to HDL cholesterol ratio and forearm bone mineral density in middle-aged and older adults

Read full text
Authors: Fangping Song, Yao Sang, Xiuyan Fang, Zilong Tang, Ling Zhang
Cited by: 0
References: 30

Abstract

Background Osteoporosis has emerged as a growing public health concern due to its high prevalence and substantial economic burden on both individuals and society. Recent studies have identified the serum uric acid to high-density lipoprotein cholesterol ratio (UHR) as a novel predictive biomarker for various diseases. However, its association with bone mineral density (BMD) remains unclear. Objective This study evaluated the association of the UHR and forearm BMD (FR-BMD) in a middle-aged and elderly cohort. We also assessed the interaction effects of age, sex, and body mass index (BMI). Methods A total of 4,958 adults aged ≥50 years were enrolled from health examinees at Heze Municipal Hospital (2022–2025). We collected demographic data, serum lipids, and uric acid levels. Measurements of FR-BMD were performed on the left distal radius (1/3 site) utilizing dual-energy X-ray absorptiometry. Multivariate linear regression analyses evaluated the UHR-BMD relationship, supplemented by subgroup analyses and interaction tests. Nonlinear associations were assessed using generalized additive models with smoothing curves. Results After adjusting for age, sex, BMI, Alb, ALP, ALT, BUN, TP, Scr, Lp(a), TC, GGT and hypertension, a higher UHR was significantly associated with lower FR-BMD [β=-0.076, 95%CI(-0.138~-0.015), P = 0.015]. Significant interaction effects were observed for age and sex ( P for interaction < 0.05). Subgroup analysis revealed that this inverse association was significant in males and overweight individuals ( P < 0.05). In contrast, a positive association was observed in females aged ≥ 60 years [ β = 0.278, 95%CI (0.126~0.430), P

Fields of Study & Subjects

Bone health and osteoporosis research Gout Hyperuricemia Uric Acid HIV-related health complications and treatments

Publication details

Journal / source
Frontiers in Endocrinology
Volume
17
Pages
1710027–1710027
Publication date
11 February 2026
Language
EN